Sarissa Capital seeks Ariad Pharma's CEO's ouster

Feb 20 (Reuters) - Sarissa Capital Management LP said it was seeking the retirement of Ariad Pharmaceuticals Inc Chief Executive Harvey Berger and would nominate its founding partner to the drugmaker's board.

from Reuters: Company News http://ift.tt/1DGgHoo

via IFTTT